Doxepin and Mirtazapine Use in Children and Adolescents With Symptoms of Insomnia — A Single-Center Retrospective Review
Authors:
- 16 November 2025
- journal article
- Published by Elsevier in Pediatric Neurology
- Vol. 175, 111-115
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Mirtazapine for chronic insomnia in older adults: a randomised double-blind placebo-controlled trial—the MIRAGE studyAge and Ageing, 2025
- Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA)Sleep Medicine, 2024
- Relationship between child sleep problems in autism spectrum disorder and parent mental health and well-beingSleep Medicine, 2023
- A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorderNeuropsychopharmacology, 2022
- Sleep in Children with Autism Spectrum DisorderCurrent Psychiatry Reports, 2017
- Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trialSleep Medicine, 2015
- Sleep and Autism Spectrum DisordersPediatric Clinics of North America, 2011
- Sleep in children with autistic spectrum disorderSleep Medicine, 2010
- The Effects of Mirtazapine on Sleep: A Placebo Controlled, Double-Blind Study in Young Healthy VolunteersSLEEP, 2002
- Mirtazapine: An Antidepressant with Noradrenergic and Specific Serotonergic EffectsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1997